Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Burning Rock Biotech Ltd ADR (NQ: BNR ) 6.447 -0.003 (-0.04%) Streaming Delayed Price Updated: 12:57 PM EDT, Jun 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 414 Open 6.380 Bid (Size) 6.290 (2) Ask (Size) 6.450 (6) Prev. Close 6.450 Today's Range 6.380 - 6.447 52wk Range 0.5722 - 8.990 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement June 03, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership June 01, 2024 Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in... Via Talk Markets Performance YTD +565.35% +565.35% 1 Month -13.92% -13.92% 3 Month +821.03% +821.03% 6 Month +565.35% +565.35% 1 Year +211.46% +211.46% More News Read More Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines May 30, 2024 From Burning Rock Biotech Limited Via GlobeNewswire BNR Stock Earnings: Burning Rock Biotech Reported Results for Q1 2024 May 29, 2024 Via InvestorPlace Burning Rock Reports First Quarter 2024 Financial Results May 29, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024 May 23, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024 May 14, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Publishes 2023 Annual Report on Form 20-F April 29, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Announces ADS Ratio Change April 26, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Three AI Stocks That Are Trading At A Discount In April 2024 April 03, 2024 Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence BNR Stock Earnings: Burning Rock Biotech Reported Results for Q4 2023 March 28, 2024 Via InvestorPlace Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results March 28, 2024 From Burning Rock Biotech Limited Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session March 11, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session February 29, 2024 Via Benzinga Burning Rock Announces Receipt of Notification from NASDAQ January 04, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Announces Results of 2023 Annual General Meeting December 19, 2023 From Burning Rock Biotech Limited Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session December 04, 2023 Via Benzinga Earnings Scheduled For November 30, 2023 November 30, 2023 Via Benzinga Burning Rock Reports Third Quarter 2023 Financial Results November 30, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023 November 22, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023 November 20, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics October 30, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test October 15, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell September 07, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Reports Second Quarter 2023 Financial Results August 31, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
